SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Aaron C. Wey, Small Animal Critical Care Medicine, 2015,

    CrossRef

  2. 2
    Mark A. Oyama, Small Animal Critical Care Medicine, 2015,

    CrossRef

  3. 3
    Richard K. Burchell, Johan Schoeman, Advances in the understanding of the pathogenesis, progression and diagnosis of myxomatous mitral valve disease in dogs, Journal of the South African Veterinary Association, 2014, 85, 1

    CrossRef

  4. 4
    A. C. Lantis, M. K. Ames, C. E. Atkins, T. C. DeFrancesco, B. W. Keene, S. R. Werre, Aldosterone breakthrough with benazepril in furosemide-activated renin-angiotensin-aldosterone system in normal dogs, Journal of Veterinary Pharmacology and Therapeutics, 2014, 37, 5
  5. 5
    Randolph L. Winter, Ashley B. Saunders, Sonya G. Gordon, Matthew W. Miller, Katharine T. Sykes, Jan S. Suchodolski, Jörg M. Steiner, Analytical validation and clinical evaluation of a commercially available high-sensitivity immunoassay for the measurement of troponin I in humans for use in dogs, Journal of Veterinary Cardiology, 2014, 16, 2, 81

    CrossRef

  6. 6
    Aurélia A. Leroux, Ali Al Haidar, Benoit Remy, Laura Borde, Simona Cerri, Rosa M.A.C. Houben, Charlotte F. Sandersen, Nassim Moula, Emmanuelle Van Erck Westergren, Hélène Amory, Atrial Natriuretic Peptide as an indicator of the severity of valvular regurgitation and heart failure in horses, Journal of Equine Veterinary Science, 2014,

    CrossRef

  7. 7
    Kun-Wei Chan, Tsung-Ying Ping, Shih-Jen Chou, Zhi-Jia Zheng, Wei-Cheng Yang, Jyh-Mirn Lai, Dan-Yuan Lo, Chih-Cheng Chang, Jui-Te Wu, CASE REPORT: TREATMENT OF AN ELDERLY DOG WITH CONCURRENT HEART DISEASE AND ACUTE UREMIA BY HEMODIALYSIS, Taiwan Veterinary Journal, 2014, 40, 02, 95

    CrossRef

  8. 8
    Chayanon Chompoosan, Chollada Buranakarl, Narongsak Chaiyabutr, Winai Chansaisakorn, Decreased sympathetic tone after short-term treatment with enalapril in dogs with mild chronic mitral valve disease, Research in Veterinary Science, 2014, 96, 2, 347

    CrossRef

  9. 9
    S. Wesselowski, M. Borgarelli, N.M. Bello, J. Abbott, Discrepancies in Identification of Left Atrial Enlargement Using Left Atrial Volume versus Left Atrial-to-Aortic Root Ratio in Dogs, Journal of Veterinary Internal Medicine, 2014, 28, 4
  10. 10
    Charlotte Misbach, Hervé P. Lefebvre, Didier Concordet, Vassiliki Gouni, Emilie Trehiou-Sechi, Amandine M.P. Petit, Cécile Damoiseaux, Alice Leverrier, Jean-Louis Pouchelon, Valérie Chetboul, Echocardiography and conventional Doppler examination in clinically healthy adult Cavalier King Charles Spaniels: Effect of body weight, age, and gender, and establishment of reference intervals, Journal of Veterinary Cardiology, 2014, 16, 2, 91

    CrossRef

  11. 11
    Anders S. Eriksson, Jens Häggström, Henrik Duelund Pedersen, Kerstin Hansson, Anna-Kaisa Järvinen, Jari Haukka, Clarence Kvart, Increased NT-proANP predicts risk of congestive heart failure in Cavalier King Charles spaniels with mitral regurgitation caused by myxomatous valve disease, Journal of Veterinary Cardiology, 2014, 16, 3, 141

    CrossRef

  12. 12
    A.B. Saunders, S.G. Gordon, M.M. Boggess, M.W. Miller, Long-Term Outcome in Dogs with Patent Ductus Arteriosus: 520 Cases (1994–2009), Journal of Veterinary Internal Medicine, 2014, 28, 2
  13. 13
    I. Ljungvall, M. Rishniw, F. Porciello, L. Ferasin, D. G. Ohad, Murmur intensity in small-breed dogs with myxomatous mitral valve disease reflects disease severity, Journal of Small Animal Practice, 2014, 55, 9
  14. 14
    Thomas H. Edwards, Amanda Erickson Coleman, Benjamin M. Brainard, Teresa C. DeFrancesco, Bernard D. Hansen, Bruce W. Keene, Amie Koenig, Outcome of positive-pressure ventilation in dogs and cats with congestive heart failure: 16 cases (1992–2012), Journal of Veterinary Emergency and Critical Care, 2014, 24, S1
  15. 15
    Tanawan Mangklabruks, Sirilak Disatian Surachetpong, Plasma and platelet serotonin concentrations in healthy dogs and dogs with myxomatous mitral valve disease, Journal of Veterinary Cardiology, 2014, 16, 3, 155

    CrossRef

  16. 16
    M.J. Reimann, J.E. Møller, J. Häggström, B. Markussen, A.E.W. Holen, T. Falk, L.H. Olsen, R-R interval variations influence the degree of mitral regurgitation in dogs with myxomatous mitral valve disease, The Veterinary Journal, 2014, 199, 3, 348

    CrossRef

  17. 17
    M.S. Kraus, K.M. Rassnick, J.J. Wakshlag, A.R.M. Gelzer, A.S. Waxman, A.M. Struble, K. Refsal, Relation of Vitamin D Status to Congestive Heart Failure and Cardiovascular Events in Dogs, Journal of Veterinary Internal Medicine, 2014, 28, 1
  18. 18
    Livia Benato, Allison Wack, Shannon N. S. Cerveny, Steven L. Rosenthal, Ellen Bronson, SURVEY OF CARDIAC PATHOLOGIES IN CAPTIVE STRIPED SKUNKS (MEPHITIS MEPHITIS), Journal of Zoo and Wildlife Medicine, 2014, 45, 2, 321

    CrossRef

  19. 19
    Shinji ARITA, Noboru ARITA, Yoshiaki HIKASA, The Effect of Pravastatin in Dogs with Mitral Regurgitation, Journal of the Japan Veterinary Medical Association, 2014, 67, 7, 506

    CrossRef

  20. 20
    Nathalie Rademacher, Romain Pariaut, Julie Pate, Carley Saelinger, Michael T. Kearney, Lorrie Gaschen, TRANSTHORACIC LUNG ULTRASOUND IN NORMAL DOGS AND DOGS WITH CARDIOGENIC PULMONARY EDEMA: A PILOT STUDY, Veterinary Radiology & Ultrasound, 2014, 55, 4
  21. 21
    Magdalena Garncarz, Marta Parzeniecka-Jaworska, Michał Jank, Magdalena Łój, A retrospective study of clinical signs and epidemiology of chronic valve disease in a group of 207 Dachshunds in Poland, Acta Veterinaria Scandinavica, 2013, 55, 1, 52

    CrossRef

  22. 22
    A.B. Saunders, S.G. Gordon, M.H. Rector, A. DeMaster, N. Jackson, F.J. Clubb, G.T. Fosgate, M.W. Miller, Bradyarrhythmias and Pacemaker Therapy in Dogs with Chagas Disease, Journal of Veterinary Internal Medicine, 2013, 27, 4
  23. 23
    J. P. MOCHEL, M. PEYROU, M. FINK, G. STREHLAU, R. MOHAMED, J. M. GIRAUDEL, B. PLOEGER, M. DANHOF, Capturing the dynamics of systemic Renin-Angiotensin-Aldosterone System (RAAS) peptides heightens the understanding of the effect of benazepril in dogs, Journal of Veterinary Pharmacology and Therapeutics, 2013, 36, 2
  24. 24
    S. Suzuki, R. Fukushima, Y. Yamamoto, T. Ishikawa, L. Hamabe, S. Kim, R. Yoshiyuki, T. Fukayama, N. Machida, R. Tanaka, Comparative Effect of Carperitide and Furosemide on Left Atrial Pressure in Dogs with Experimentally Induced Mitral Valve Regurgitation, Journal of Veterinary Internal Medicine, 2013, 27, 5
  25. 25
    S.M. Scruggs, M. Rishniw, Dermatologic Adverse Effect of Subcutaneous Furosemide Administration in a Dog, Journal of Veterinary Internal Medicine, 2013, 27, 5
  26. 26
    Marisa K. Ames, Clarke E. Atkins, Andrea C. Lantis, Stephen R. Werre, Effect of furosemide and high-dosage pimobendan administration on the renin-angiotensin-aldosterone system in dogs, American Journal of Veterinary Research, 2013, 74, 8, 1084

    CrossRef

  27. 27
    Eryn A. Shipley, Daniel F. Hogan, Nonya N. Fiakpui, Aliya N. Magee, Henry W. Green III, Kimberly A. Sederquist, In vitro effect of pimobendan on platelet aggregation in dogs, American Journal of Veterinary Research, 2013, 74, 3, 403

    CrossRef

  28. 28
    A. Tidholm, K. Höglund, J. Häggström, A. Bodegård-Westling, I. Ljungvall, Left Atrial Ejection Fraction Assessed by Real-Time 3-Dimensional Echocardiography in Normal Dogs and Dogs with Myxomatous Mitral Valve Disease, Journal of Veterinary Internal Medicine, 2013, 27, 4
  29. 29
    J. Häggström, A. Boswood, M. O'Grady, O. Jöns, S. Smith, S. Swift, M. Borgarelli, B. Gavaghan, J.-G. Kresken, M. Patteson, B. Åblad, C.M. Bussadori, T. Glaus, A. Kovačević, M. Rapp, R.A. Santilli, A. Tidholm, A. Eriksson, M.C. Belanger, M. Deinert, C.J.L. Little, C. Kvart, A. French, M. Rønn-Landbo, G. Wess, A. Eggertsdottir, M. Lynne O'Sullivan, M. Schneider, C.W. Lombard, J. Dukes-McEwan, R. Willis, A. Louvet, R. DiFruscia, Longitudinal Analysis of Quality of Life, Clinical, Radiographic, Echocardiographic, and Laboratory Variables in Dogs with Myxomatous Mitral Valve Disease Receiving Pimobendan or Benazepril: The QUEST Study, Journal of Veterinary Internal Medicine, 2013, 27, 6
  30. 30
    Teresa C. DeFrancesco, Management of Cardiac Emergencies in Small Animals, Veterinary Clinics of North America: Small Animal Practice, 2013, 43, 4, 817

    CrossRef

  31. 31
    Takuma AOKI, Yoko FUJII, Hiroshi SUNAHARA, Hiroshi TAKANO, Yoshito WAKAO, Modified Loop Technique in Three Dogs with Mitral Regurgitation, Journal of Veterinary Medical Science, 2013, 75, 1, 107

    CrossRef

  32. 32
    Carlo Guglielmini, Helen Poser, Angela Dalla Pria, Michele Drigo, Elisa Mazzotta, Michele Berlanda, Alessia Luciani, Red blood cell distribution width in dogs with chronic degenerative valvular disease, Journal of the American Veterinary Medical Association, 2013, 243, 6, 858

    CrossRef

  33. 33
    L. Ferasin, L. Crews, D.S. Biller, K.E. Lamb, M. Borgarelli, Risk Factors for Coughing in Dogs with Naturally Acquired Myxomatous Mitral Valve Disease, Journal of Veterinary Internal Medicine, 2013, 27, 2
  34. 34
    J. Häggström, P.F. Lord, K. Höglund, I. Ljungvall, O. Jöns, C. Kvart, K. Hansson, Short-Term Hemodynamic and Neuroendocrine Effects of Pimobendan and Benazapril in Dogs with Myxomatous Mitral Valve Disease and Congestive Heart Failure, Journal of Veterinary Internal Medicine, 2013, 27, 6
  35. 35
    A.M. Petit, V. Gouni, R. Tissier, E. Trehiou-Sechi, C. Misbach, J.-L. Pouchelon, H.P. Lefebvre, V. Chetboul, Systolic arterial blood pressure in small-breed dogs with degenerative mitral valve disease: A prospective study of 103 cases (2007–2012), The Veterinary Journal, 2013, 197, 3, 830

    CrossRef

  36. You have free access to this content36
    Johanna Wolf, Nicola Gerlach, Karin Weber, André Klima, Gerhard Wess, The diagnostic relevance of NT-proBNP and proANP 31–67 measurements in staging of myxomatous mitral valve disease in dogs, Veterinary Clinical Pathology, 2013, 42, 2
  37. 37
    Susan W. Volk, Christine Theoret, Translating stem cell therapies: The role of companion animals in regenerative medicine, Wound Repair and Regeneration, 2013, 21, 3
  38. 38
    Chris Degeling, Ian Kerridge, Melanie Rock, What to Think of Canine Obesity? Emerging Challenges to Our Understanding of Human–Animal Health Relationships, Social Epistemology, 2013, 27, 1, 90

    CrossRef

  39. 39
    Kimberly L. Boyle, Elizabeth Leech, A review of the pharmacology and clinical uses of pimobendan., Journal of Veterinary Emergency and Critical Care, 2012, 22, 4
  40. 40
    Melanie J. Hezzell, Adrian Boswood, Yu-Mei Chang, Walasinee Moonarmart, Jonathan Elliott, Associations among serum N-terminal procollagen type III concentration, urinary aldosterone-to-creatinine ratio, and ventricular remodeling in dogs with myxomatous mitral valve disease, American Journal of Veterinary Research, 2012, 73, 11, 1765

    CrossRef

  41. 41
    Shuji Suzuki, Ryuji Fukushima, Taisuke Ishikawa, Yuta Yamamoto, Lina Hamabe, Soomin Kim, Rieko Yoshiyuki, Noboru Machida, Ryou Tanaka, Comparative effects of amlodipine and benazepril on Left Atrial Pressure in Dogs with experimentally-induced Mitral Valve Regurgitation, BMC Veterinary Research, 2012, 8, 1, 166

    CrossRef

  42. 42
    Marco BaronToaldo, Alessia Diana, Giorgia Sgreccia, Mario Cipone, ECG of the Month, Journal of the American Veterinary Medical Association, 2012, 240, 12, 1419

    CrossRef

  43. 43
    Gordon D. Peddle, Gretchen E. Singletary, Caryn A. Reynolds, Dennis J. Trafny, Maggie C. Machen, Mark A. Oyama, Effect of torsemide and furosemide on clinical, laboratory, radiographic and quality of life variables in dogs with heart failure secondary to mitral valve disease, Journal of Veterinary Cardiology, 2012, 14, 1, 253

    CrossRef

  44. 44
    Stephen J. Ettinger, Giosi Farace, Scott D. Forney, Michelle Frye, Andrew Beardow, Evaluation of plasma N-terminal pro-B-type natriuretic peptide concentrations in dogs with and without cardiac disease, Journal of the American Veterinary Medical Association, 2012, 240, 2, 171

    CrossRef

  45. 45
    Danielle N. Smith, John D. Bonagura, Nicole M. Culwell, Karsten E. Schober, Left ventricular function quantified by myocardial strain imaging in small-breed dogs with chronic mitral regurgitation, Journal of Veterinary Cardiology, 2012, 14, 1, 231

    CrossRef

  46. 46
    Peter Lord, Kerstin Hansson, Cristina Carnabuci, Clarence Kvart, Jens Häggström, Letter to the Editor, Journal of Veterinary Internal Medicine, 2012, 26, 2
  47. 47
    Masami Uechi, Takahiro Mizukoshi, Takeshi Mizuno, Masashi Mizuno, Kayoko Harada, Takashi Ebisawa, Junichirou Takeuchi, Tamotsu Sawada, Shuhei Uchida, Asako Shinoda, Arane Kasuya, Masaaki Endo, Miki Nishida, Shota Kono, Megumi Fujiwara, Takashi Nakamura, Mitral valve repair under cardiopulmonary bypass in small-breed dogs: 48 cases (2006–2009), Journal of the American Veterinary Medical Association, 2012, 240, 10, 1194

    CrossRef

  48. 48
    R.B. Nogueira, A.C. Silva, G.F.M. Reis, R.A.L. Muzzi, M.M. Mantovani, Muscular arterial impedance in dogs with chronic degenerative mitral valve disease, Research in Veterinary Science, 2012, 93, 3, 1434

    CrossRef

  49. 49
    Clarke E. Atkins, Jens Häggström, Pharmacologic management of myxomatous mitral valve disease in dogs, Journal of Veterinary Cardiology, 2012, 14, 1, 165

    CrossRef

  50. 50
    Caryn A. Reynolds, Dorothy Cimino Brown, John E. Rush, Philip R. Fox, Thaibihn P. Nguyenba, Linda B. Lehmkuhl, Sonya G. Gordon, Heidi B. Kellihan, Rebecca L. Stepien, Bonnie K. Lefbom, C. Kate Meier, Mark A. Oyama, Prediction of first onset of congestive heart failure in dogs with degenerative mitral valve disease: The PREDICT cohort study, Journal of Veterinary Cardiology, 2012, 14, 1, 193

    CrossRef

  51. 51
    Sonya G. Gordon, Ashley B. Saunders, Crystal D. Hariu, May M. Boggess, Matthew W. Miller, Retrospective review of carvedilol administration in 38 dogs with preclinical chronic valvular heart disease, Journal of Veterinary Cardiology, 2012, 14, 1, 243

    CrossRef

  52. 52
    Melanie J. Hezzell, Adrian Boswood, Walasinee Moonarmart, Jonathan Elliott, Selected echocardiographic variables change more rapidly in dogs that die from myxomatous mitral valve disease, Journal of Veterinary Cardiology, 2012, 14, 1, 269

    CrossRef

  53. 53
    E. Christopher Orton, Carla M.R. Lacerda, Holly B. MacLea, Signaling pathways in mitral valve degeneration, Journal of Veterinary Cardiology, 2012, 14, 1, 7

    CrossRef

  54. 54
    Carla M.R. Lacerda, Holly B. MacLea, John D. Kisiday, E. Christopher Orton, Static and cyclic tensile strain induce myxomatous effector proteins and serotonin in canine mitral valves, Journal of Veterinary Cardiology, 2012, 14, 1, 223

    CrossRef

  55. 55
    M. Borgarelli, S. Crosara, K. Lamb, P. Savarino, G. La Rosa, A. Tarducci, J. Haggstrom, Survival Characteristics and Prognostic Variables of Dogs with Preclinical Chronic Degenerative Mitral Valve Disease Attributable to Myxomatous Degeneration, Journal of Veterinary Internal Medicine, 2012, 26, 1
  56. 56
    Ashley B. Saunders, The Diagnosis and Management of Age-Related Veterinary Cardiovascular Disease, Veterinary Clinics of North America: Small Animal Practice, 2012, 42, 4, 655

    CrossRef

  57. 57
    Ian D. Jones, Virginia Luis Fuentes, Adrian Boswood, Melanie J. Hezzell, David Wrigglesworth, Ana Mateus, Walasinee Moonarmart, Jonathan Elliott, Ultrasonographic measurement of flow-mediated vasodilation in dogs with chronic valvular disease, Journal of Veterinary Cardiology, 2012, 14, 1, 203

    CrossRef

  58. 58
    C. E. Atkins, A. C. Lantis, M. K. Ames, S. Y. Gardner, Utility of Urinary Aldosterone Measurement in Quantitating RAAS Activation, Journal of Veterinary Pharmacology and Therapeutics, 2012, 35, 5
  59. 59
    John D. Bonagura, Linda B. Lehmkuhl, Helio Autran de Morais, Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice, 2012,

    CrossRef

  60. 60
    Ian D. Jones, Virginia Luis Fuentes, David Wrigglesworth, Emily Mort, Jonathan Elliott, Comparison of flow-mediated vasodilation in femoral and brachial arteries in healthy dogs, American Journal of Veterinary Research, 2011, 72, 8, 1029

    CrossRef

  61. 61
    Agnieszka Noszczyk-Nowak, Anna Szałas, Urszula Pasławska, Józef Nicpoń, Comparison of P-wave dispersion in healthy dogs, dogs with chronic valvular disease and dogs with disturbances of supraventricular conduction, Acta Veterinaria Scandinavica, 2011, 53, 1, 18

    CrossRef

  62. 62
    Andrea C. Lantis, Clarke E. Atkins, Teresa C. DeFrancesco, Bruce W. Keene, Stephen R. Werre, Effects of furosemide and the combination of furosemide and the labeled dosage of pimobendan on the circulating renin-angiotensin-aldosterone system in clinically normal dogs, American Journal of Veterinary Research, 2011, 72, 12, 1646

    CrossRef

  63. 63
    K. Nakamura, M. Yamasaki, H. Ohta, N. Sasaki, M. Murakami, W. R. Bandula Kumara, M. Takiguchi, Effects of sildenafil citrate on five dogs with Eisenmenger’s syndrome, Journal of Small Animal Practice, 2011, 52, 11
  64. 64
    James N.B.M. de Andrade, E. Christopher Orton, June Boon, Celina T.D. Nishimori, Claudio Olivaes, Aparecido A. Camacho, Partial external mitral annuloplasty in dogs with myxomatous mitral valve degeneration and congestive heart failure: Outcome in 9 cases, Journal of Veterinary Cardiology, 2011, 13, 3, 197

    CrossRef

  65. 65
    P.F. Lord, K. Hansson, C. Carnabuci, C. Kvart, J Häggström, Radiographic Heart Size and Its Rate of Increase as Tests for Onset of Congestive Heart Failure in Cavalier King Charles Spaniels with Mitral Valve Regurgitation, Journal of Veterinary Internal Medicine, 2011, 25, 6
  66. 66
    S. Suzuki, R. Fukushima, T. Ishikawa, L. Hamabe, D. Aytemiz, H. Huai-Che, S. Nakao, N. Machida, R. Tanaka, The Effect of Pimobendan on Left Atrial Pressure in Dogs with Mitral Valve Regurgitation, Journal of Veterinary Internal Medicine, 2011, 25, 6
  67. 67
    Sonja Fonfara, Lourdes de la Heras Alegret, Alexander J. German, Laura Blackwood, Joanna Dukes-McEwan, P-J. M. Noble, Rachel D. Burrow, Underlying diseases in dogs referred to a veterinary teaching hospital because of dyspnea: 229 cases (2003–2007), Journal of the American Veterinary Medical Association, 2011, 239, 9, 1219

    CrossRef

  68. 68
    Mark A. Oyama, Gordon D. Peddle, Caryn A. Reynolds, Gretchen E. Singletary, Use of the loop diuretic torsemide in three dogs with advanced heart failure, Journal of Veterinary Cardiology, 2011, 13, 4, 287

    CrossRef

  69. 69
    Michele Borgarelli, Jens Haggstrom, Canine Degenerative Myxomatous Mitral Valve Disease: Natural History, Clinical Presentation and Therapy, Veterinary Clinics of North America: Small Animal Practice, 2010, 40, 4, 651

    CrossRef

  70. 70
    Adrian Boswood, Current Use of Pimobendan in Canine Patients with Heart Disease, Veterinary Clinics of North America: Small Animal Practice, 2010, 40, 4, 571

    CrossRef

  71. 71
    P. Lord, K. Hansson, C. Kvart, J. Häggström, Rate of change of heart size before congestive heart failure in dogs with mitral regurgitation, Journal of Small Animal Practice, 2010, 51, 4
  72. 72
    E. Christopher Orton, Valvular Heart Disease,